JPMorgan raises combined Spire Healthcare stake to 5.451563%
JPMorgan Chase disclosed a 5.451563% position in Spire Healthcare, comprising 4.851279% through financial instruments and 0.600284% in shares.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
The London Stock Exchange, through its RNS service, reported that JPMorgan Chase & Co. notified Spire Healthcare Group PLC of a threshold crossing. The threshold was reached on 8 October 2026, while the issuer received the notification on 12 October 2026.
JPMorgan’s combined position amounted to 5.451563%, representing 21,956,692 voting rights. Direct and indirect voting rights attached to shares accounted for 0.600284%, or 2,417,703 rights, while financial instruments represented 4.851279%. The previous notification showed a combined position of 5.338732%.
The financial-instrument exposure consisted of cash-settled equity swaps expiring between 27 January 2027 and 8 May 2031. The two largest positions represented 7,777,948 and 7,069,080 voting rights.
why it matters
The filing indicates that JPMorgan’s disclosed economic exposure to Spire Healthcare increased from the previous notification. Most of the position is held through cash-settled instruments rather than direct share ownership.
instruments
sources
- REG - Spire Healthcare Grp JPMorgan Chase & Co - Holding(s) in Company — London Stock Exchange, 12 October 2026 at 11:09 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗